Adequate tidal volume could triple the chances of survival for patients experiencing cardiac arrest (13.5% versus 4.1%; P<0.0001).
Références Etude: Idris, A. H., Aramendi Ecenarro, E., Leroux, B., Jaureguibeitia, X., Yang, B. Y., Shaver, S., … Wang, H. E. (2023). Bag-Valve-Mask Ventilation and Survival From Out-of-Hospital Cardiac Arrest: A Multicenter Study. Circulation, 148. DOI: 10.1161/CIRCULATIONAHA.123.065561.
Adequate tidal volume could quintuple the rates of favorable neurological outcomes (10.6% versus 2.4%; P < 0.0001).
Références Etude: Idris, A. H., Aramendi Ecenarro, E., Leroux, B., Jaureguibeitia, X., Yang, B. Y., Shaver, S., … Wang, H. E. (2023). Bag-Valve-Mask Ventilation and Survival From Out-of-Hospital Cardiac Arrest: A Multicenter Study. Circulation, 148. DOI: 10.1161/CIRCULATIONAHA.123.065561.
60% of patients do not receive an adequate tidal volume.
Références Etude: Idris, A. H., Aramendi Ecenarro, E., Leroux, B., Jaureguibeitia, X., Yang, B. Y., Shaver, S., … Wang, H. E. (2023). Bag-Valve-Mask Ventilation and Survival From Out-of-Hospital Cardiac Arrest: A
5 hours run time
Replaceable external battery
Weight : 150g +/- 5g
Ventilation mode 30 : 2
Continuous ventilation mode
3 patient’s heights
FlowSens is a biocompatible digital flow sensor. It is single use to eliminate contamination risks between patients.
The ultimate training tool for high-performance manual ventilation.
References (I)Jean-Baptiste Pretalli, Da Cunha Marie, Saïd Hachimi-Idrissi, Laure-Estelle Piller, Abdo Khoury, Real-world adoption and use of a ventilation feedback device during out-of-hospital cardiac arrest: a population-based observational study from a French prehospital system, Resuscitation Plus, 2026, 101465, ISSN 26665204, https://doi.org/10.1016/j.resplu.2026.101465. (II)(III) Khoury, Abdoa,b ; Hachimi-Idrissi, Saidc,d,e ; The RACE Study Group. Ventilation feedback devices in cardiopulmonary resuscitation: bridging the gap for optimal resuscitation practices. European Journal of Emergency Medicine ():10.1097/MEJ.0000000000001252, July 07, 2025. | DOI: 10.1097/MEJ.0000000000001252
Legal mentions US : EOlife is a Class II FDA cleared medical device.
EOlife
The only ventilation feedback device (VFD) to calculate the volume of gas reaching the patient's lungs (tidal volume).
EOlife is associated with a tripled neurologically intact survival (1)
It’s time to put the “P” back in “CPR”
x3
x5
60%
The integration of VFDs like EOlife «is a vital strategy for ensuring the highest standards of emergency care.» (2)
«Integrating VFDs into routine resuscitation is crucial for bridging the gap between guidelines and clinical practice.» (3)
International experts recognize EOlife as the new standard of care
Designed for extreme conditions
EOlife is designed for use in all types of conditions.
Impact resistance
Temperatures
Water resistant
Tech Specs
Ergonomic software
Flowsense sensor
EOlife X
Need more information? Find the answers to your questions in our FAQ.
The LAB
Users' Stories
Behind the Tech
Science's New
EU : EOlife is a Medical device, Class I according to MDR 2017/745
See instructions for use for more information. Link to the full legal-information page: https://archeon-medical.com/legal-mentions/
en
